Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Healthcare Industry News Stryker strengthens orthopedic portfolio with $220m acquisition of OrthoSpace US medical technology giant Stryker has acquired Israeli firm OrthoSpace in a major all-cash deal valued at up… bypharmanewsdailyMarch 21, 2019